Immune surveillance system can detect more efficiently secretory
tumor-specific
antigens, which are superior as a target for
cancer immunotherapy. On the contrary, immune tolerance can be induced in the thymus when a
tumor antigen is massively secreted into circulation. Thus, the secretion of
tumor-specific
antigen may have contradictory roles in
tumor immunity in a context-dependent manner. However, it remains elusive on the precise cellular mechanism of intrathymic immune tolerance against
tumor antigens. We previously demonstrated that a minor thymic conventional dendritic cell (cDC) subset, CD8α(-)Sirpα(+)
cDCs, but not the major subset, CD8α(+)Sirpα(-)
cDCs can selectively capture blood-borne
antigens and crucially contribute to the self-tolerance. In the present study, we further demonstrated that Sirpα(+)
cDCs can capture a blood-borne
antigen leaking inside the interlobular vascular-rich regions (IVRs). Blood-borne
antigen selectively captured by Sirpα(+)
cDCs can induce
antigen-specific Treg generation or negative selection, depending on the immunogenicity of the presented
antigen. Furthermore, CCR2 expression by thymic Sirpα(+)
cDCs and abundant expression of its
ligands, particularly, CCL2 by
tumor-bearing mice prompted us to examine the function of thymic Sirpα(+)
cDCs in
tumor-bearing mice. Interestingly,
tumor-bearing mice deposited CCL2 inside IVRs in the thymus. Moreover,
tumor formation induced the accumulation of Sirpα(+)
cDCs in IVRs under the control of CCR2-CCL2 axis and enhanced their capacity to take up
antigens, resulting in the shift from Treg differentiation to negative selection. Finally, intrathymic negative selection similarly ensued in CCR2-competent mice once the
tumor-specific
antigen was secreted into bloodstream. Thus, we demonstrated that thymic Sirpα(+)
cDCs crucially contribute to this novel process of intrathymic
tumor immune tolerance.